Understanding the Essentialities in Establishing the Bioequivalence of Oral Inhalation Drug Products to be Marketed in the USA-Reference-Cited by-同舟云学术

Understanding the Essentialities in Establishing the Bioequivalence of Oral Inhalation Drug Products to be Marketed in the USA

Published:2019-12-06 Issue:4 Volume:54 Page:738-748
ISSN:2168-4790
Container-title:Therapeutic Innovation & Regulatory Science
language:en
Short-container-title:Ther Innov Regul Sci

Author:

Fernandes Swapnil Dylan,Koland Marina

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s43441-019-00007-3.pdf

Reference26 articles.

1. Soriano JB, Abajobir AA, Abate KH, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. https://doi.org/10.1016/S2213-2600(17)30293-X.

2. 3 M. Mastering change in inhalation drug delivery. 2014. [cited 1 May 2019]. http://multimedia.3m.com/mws/media/1159481O/mastering-change-in-inhalation-drug-delivery.pdf.

3. Hess DR. Metered-dose inhalers and dry powder inhalers in aerosol therapy. Respir Care. 2005;50(10):1376–83.

4. Islam N, Gladki E. Dry powder inhalers (DPIs)—a review of device reliability and innovation. Int J Pharm. 2008;360(1–2):1–11. https://doi.org/10.1016/J.IJPHARM.2008.04.044.

5. Sahiti KG. Nebulizers: a review paper. Int J Adv Res Comput Sci. 2017;8(5):1697–9.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AMELIORATION IN APPROACHES FOR ENHANCED PULMONARY DRUG DELIVERY;Asian Journal of Pharmaceutical and Clinical Research;2023-10-07